Skip to main content
OpenTrials
Completed

NCT Number: NCT05249803

"Clinical Characteristics, Comorbidities and Outcome of Critically Sick Patients With COVID-19

COVID-19, caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), is a multisystem disease which primarily involves the respiratory tract. The first case of COVID-19 was identified in late 2019 in the province of Wuhan, China which was followed by the rapid spread of the disease globally, becoming a present-day pandemic.

Objectives: The aim of this study was to describe the clinical characteristics, comorbidities and outcome of the critically sick patients with COVID-19 pneumonia admitted in ICU of a tertiary care hospital in Lahore.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID-19 Pneumonia COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

16 year–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Fatima Memorial Hospital College of Medicine & Dentistry

Lahore, Punjab Province, 54000, Pakistan

About this study

Objectives: The aim of this study was to describe the clinical characteristics, comorbidities and outcome of the critically sick patients with COVID-19 pneumonia admitted in ICU of a tertiary care hospital in Lahore.

Material & Methods:

Study design: Retrospective study. Study Settings: Study was conducted in Fatima Memorial Hospital, Lahore. Study Duration: Study was conducted on Covid-19 patients who were admitted from March 2021 to August 2021.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Critically sick patients with COVID-19 Pneumonia
  • All admitted ICU patients with a diagnosis of COVID-19 pneumonia
  • Patients having positive reverse transcriptase PCR for COVID-19
  • Patients with High-resolution computed tomography (HRCT) chest findings suggestive of COVID-related lung injury
  • All patients above 16 years of age with both genders( males and females)

Exclusion criteria

  • All patients with PCR negative with mild symptoms
  • Patients with No signs of COVID-19 pneumonia on HRCT chest

Treatment and study plan

Patients with COVID-19 Pneumonia

Combination Product

Patients were offered with usual care of COVID-19 in ICU and we did retrospective study

Primary outcomes

  1. Mortality

    Time frame: 6 months

    The primary endpoint of the study will be to assess the ICU mortality (in percentages% and Numbers) of critically sick patients with COVID-19 pneumonia admitted to the intensive care unit

Secondary outcomes

  1. Comorbidities

    Time frame: 6 months

    we will assess various comorbidities in critically sick patients with COVID-19 pneumonia admitted to the intensive care unit

Sponsors and collaborators

Lead sponsor

FMH College of Medicine and Dentistry

Other

Registry information

Official study title

"Clinical Characteristics, Comorbidities and Outcome of Critically Sick Patients With COVID-19 Pneumonia Admitted in Intensive Care Unit of a Tertiary Care Hospital in Lahore, Pakistan": A Retrospective Cohort Study

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Feb 22, 2022
Registry last updated
Feb 22, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.